FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions

被引:111
|
作者
Ahmadzadeh, Mojgan [1 ]
Felipe-Silva, Aloisio [2 ]
Heemskerk, Bianca [1 ]
Powell, Daniel J., Jr. [1 ]
Wunderlich, John R. [1 ]
Merino, Maria J. [2 ]
Rosenberg, Steven A. [1 ]
机构
[1] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA
[2] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1182/blood-2008-06-163048
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Regulatory T(T-reg) cells are often found in human tumors; however, their functional characteristics have been difficult to evaluate due to low cell numbers and the inability to adequately distinguish between activated and T-reg cell populations. Using a novel approach, we examined the intracellular cytokine production capacity of tumor-infiltrating T cells in the single-cell suspensions of enzymatically digested tumors to differentiate T-reg cells from effector T cells. Similar to T-reg cells in the peripheral blood of healthy individuals, tumor-infiltrating FOXP3 + CD4 T cells, unlike FOXP3 + T cells, were unable to produce IL-2 and IFN-gamma upon ex vivo stimulation, indicating that FOXP3 expression is a valid biological marker for human T-reg cells even in the tumor microenvironment. Accordingly, we enumerated FOXP3 + CD4 T-reg cells in intratumoral and peritumoral sections of metastatic melanoma tumors and found a significant increase in proportion of FOXP3 + CD4 T-reg cells in the intratumoral compared with peritumoral areas. Moreover, their frequencies were 3-to 5-fold higher in tumors than in peripheral blood from the same patients or healthy donors, respectively. These findings demonstrate that the tumor-infiltrating CD4 T-reg cell population is accurately depicted by FOXP3 expression, they selectively accumulate in tumors, and their frequency in peripheral blood does not properly reflect tumor microenvironment. (Blood. 2008; 112: 4953-4960)
引用
收藏
页码:4953 / 4960
页数:8
相关论文
共 50 条
  • [1] FOXP3 Defines Regulatory T Cells in Human Tumor and Autoimmune Disease
    Kryczek, Ilona
    Liu, Rebecca
    Wang, Guobin
    Wu, Ke
    Shu, Xiaogong
    Szeliga, Wojciech
    Vatan, Linhua
    Finlayson, Emily
    Huang, Emina
    Simeone, Diane
    Redman, Bruce
    Welling, Theodore H.
    Chang, Alfred
    Zou, Weiping
    CANCER RESEARCH, 2009, 69 (09) : 3995 - 4000
  • [2] Regulatory T cells and Foxp3
    Rudensky, Alexander Y.
    IMMUNOLOGICAL REVIEWS, 2011, 241 : 260 - 268
  • [3] CREMALPHA DESTABILIZES FOXP3 EXPRESSION IN REGULATORY T CELLS
    Ohl, K.
    Rauen, T.
    Tenbrock, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 71 - 71
  • [4] The adaptability of regulatory T cells and Foxp3
    Hori, Shohei
    Murakami, Ryuichi
    INTERNATIONAL IMMUNOLOGY, 2021, 33 (12) : 803 - 807
  • [5] FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents
    Ohkura, Naganari
    Hamaguchi, Masahide
    Sakaguchi, Shimon
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2011, 32 (03) : 158 - 166
  • [6] Hyperthermia regulates FOXP3 expression in human FOXP3+regulatory T cells
    Dat Tran
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [7] Foxp3 expression in T regulatory cells and other cell lineages
    Christel Devaud
    Phillip K. Darcy
    Michael H. Kershaw
    Cancer Immunology, Immunotherapy, 2014, 63 : 869 - 876
  • [8] Epigenetic control of stable Foxp3 expression in regulatory T cells
    Huehn, J.
    IMMUNOLOGY, 2013, 140 : 4 - 4
  • [9] Foxp3 expression in T regulatory cells and other cell lineages
    Devaud, Christel
    Darcy, Phillip K.
    Kershaw, Michael H.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2014, 63 (09) : 869 - 876
  • [10] Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma
    Karagiannidis, C
    Akdis, M
    Holopainen, P
    Woolley, NJ
    Hense, G
    Rückert, B
    Mantel, PY
    Menz, G
    Akdis, CA
    Blaser, K
    Schmidt-Weber, CB
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (06) : 1425 - 1433